Friedman Charlene A 4
4 · MAP Pharmaceuticals, Inc. · Filed Mar 13, 2012
Insider Transaction Report
Form 4
Friedman Charlene A
VP President, Gen Counsel &Sec
Transactions
- Sale
Common Stock
2012-03-09$17.50/sh−10,000$175,000→ 1,307 total - Exercise/Conversion
Common Stock
2012-03-09$12.37/sh+10,000$123,723→ 11,307 total - Exercise/Conversion
Stock Option (Right to Buy)
2012-03-09−10,000→ 22,328 totalExercise: $12.37Exp: 2017-07-23→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]The sale of the reported shares is made pursuant to terms of 10b5-1 plan in effect at the time of sale of the shares.
- [F2]The option is exercisable as it vests: 25% of the total number of option shares vests and becomes exercisable on the first anniversary of the vesting commencement date. Thereafter, 1/48th of the total number of option shares becomes exercisable cumulatively on each monthly anniversary for 36 months so that the entire number of option shares becomes fully vested.